1. Home
  2. Search

Search

Search results

50 results found

Safety and immunogenicity of a Zika purified inactivated virus vaccine given via standard, accelerated, or shortened schedules: a single-centre, double-blind, sequential-group, randomised, placebo-controlled, phase 1 trial

Publication: Journal Article
Stephenson, Kathryn E., Chen Sabrina Tan, Stephen R. Walsh-, -Kayvon Modjarrad, and Dan H. Barouch. 2020. “Safety and Immunogenicity of a Zika Purified Inactivated Virus Vaccine Given via Standard, Accelerated, or Shortened Schedules: A Single-Centre, Double-Blind, Sequential-Group, Randomised, Placebo-Controlled, Phase 1 Trial”. Lancet Infectious Diseases 20 (9): 1061-70.

Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Household Transmission during the Omicron Era in Massachusetts: A Prospective, Case-Ascertained Study using Genomic Epidemiology

Publication: Journal Article
Banga, Jaspreet, Taylor Brock-Fisher, Brittany A. Petros-, -Pardis C. Sabeti, and Kathryn E. Stephenson. 2024. “Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Household Transmission During the Omicron Era in Massachusetts: A Prospective, Case-Ascertained Study Using Genomic Epidemiology”. MedRxiv.

Kathryn Stephenson, MD, MPH

Person: Principal Investigator, HVTN CRS Leader
Dr. Stephenson is a physician-scientist in the Center for Virology and Vaccine Research (CVVR) and the Division of Infectious Diseases at Beth Israel Deaconess Medical Center (BIDMC) in Boston, Massachusetts. She is also an Associate Professor of Medicine at Harvard Medical School. She has expertise...

Maura Galligan Crowther, RN, MSN, FNP-C

Person: Clinical Research Nurse Practitioner
Maura is a Clinical Research Nurse Practitioner who joined the CVVR in 2022. Her interest in infectious disease, disease prevention, and global health issues is what drew her to the CVVR and she is thrilled to be part of a team dedicated to advancing research and making positive impacts in these...

Jaspreet Banga, MD, MPH

Person: Clinical and Research Postdoctoral Fellow
Dr. Banga is a 3rd-year infectious diseases fellow at BIDMC, and a postdoctoral research fellow in the Stephenson Group. She is a graduate of Rutgers-New Jersey Medical School and is an investigator for the HIV Vaccine Trials Network.